Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia
Type 2 diabetes mellitus (T2DM) is a chronic disease with high-cost treatment. This study aimed to analyze the cost-effectiveness of T2DM treatment in hospitalized patients with complications of kidney and peripheral vascular disease (PVD) in Indonesia by focusing on patients of Health Social Securi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920312/ https://www.ncbi.nlm.nih.gov/pubmed/33669379 http://dx.doi.org/10.3390/healthcare9020211 |
_version_ | 1783658252134776832 |
---|---|
author | Priyadi, Akhmad Permana, Hikmat Muhtadi, Ahmad Sumiwi, Sri A. Sinuraya, Rano K. Suwantika, Auliya A. |
author_facet | Priyadi, Akhmad Permana, Hikmat Muhtadi, Ahmad Sumiwi, Sri A. Sinuraya, Rano K. Suwantika, Auliya A. |
author_sort | Priyadi, Akhmad |
collection | PubMed |
description | Type 2 diabetes mellitus (T2DM) is a chronic disease with high-cost treatment. This study aimed to analyze the cost-effectiveness of T2DM treatment in hospitalized patients with complications of kidney and peripheral vascular disease (PVD) in Indonesia by focusing on patients of Health Social Security Agency (BPJS Kesehatan). An observational study was applied by collecting data retrospectively from patients’ medical record at the biggest public hospital in West Java Province, Indonesia. Two perspectives of payer and healthcare provider were applied to estimate the treatment cost. We considered following inclusion criteria: (i) Hospitalized T2DM patients without complication, with complications of kidney and PVD during 2014–2017; (ii) member of BPJS Kesehatan; (iii) >18 years old patients; and (iv) patients with complete medical record data. The results showed that the majority patients were female (56.72%), 45–64 years old (69.40%), and had a length of stay at 4–10 days (54.48%). The greatest contributions in the total treatment cost were found to be hospital room, medical services and medicines for the treatment of T2DM without complications, with complications of kidney and PVD, respectively. From the perspective of payer, the incremental cost-effectiveness ratios (ICERs) of T2DM treatment with complications of kidney and PVD would be IDR 215,723 and IDR 234,591 per 1 mg/dL blood glucose reduction, respectively. From the perspective of healthcare provider, the ICERs of T2DM treatment with complications of kidney and PVD would be IDR 166,289 and IDR 681,853 per 1 mg/dL blood glucose reduction in both perspectives (1 US$ = IDR 13,451). In a comparison with T2DM without complication, reducing 1 mg/dL blood glucose in T2DM treatment with complication of PVD would require higher cost than in T2DM treatment with complication of kidney from both perspectives. |
format | Online Article Text |
id | pubmed-7920312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79203122021-03-02 Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia Priyadi, Akhmad Permana, Hikmat Muhtadi, Ahmad Sumiwi, Sri A. Sinuraya, Rano K. Suwantika, Auliya A. Healthcare (Basel) Article Type 2 diabetes mellitus (T2DM) is a chronic disease with high-cost treatment. This study aimed to analyze the cost-effectiveness of T2DM treatment in hospitalized patients with complications of kidney and peripheral vascular disease (PVD) in Indonesia by focusing on patients of Health Social Security Agency (BPJS Kesehatan). An observational study was applied by collecting data retrospectively from patients’ medical record at the biggest public hospital in West Java Province, Indonesia. Two perspectives of payer and healthcare provider were applied to estimate the treatment cost. We considered following inclusion criteria: (i) Hospitalized T2DM patients without complication, with complications of kidney and PVD during 2014–2017; (ii) member of BPJS Kesehatan; (iii) >18 years old patients; and (iv) patients with complete medical record data. The results showed that the majority patients were female (56.72%), 45–64 years old (69.40%), and had a length of stay at 4–10 days (54.48%). The greatest contributions in the total treatment cost were found to be hospital room, medical services and medicines for the treatment of T2DM without complications, with complications of kidney and PVD, respectively. From the perspective of payer, the incremental cost-effectiveness ratios (ICERs) of T2DM treatment with complications of kidney and PVD would be IDR 215,723 and IDR 234,591 per 1 mg/dL blood glucose reduction, respectively. From the perspective of healthcare provider, the ICERs of T2DM treatment with complications of kidney and PVD would be IDR 166,289 and IDR 681,853 per 1 mg/dL blood glucose reduction in both perspectives (1 US$ = IDR 13,451). In a comparison with T2DM without complication, reducing 1 mg/dL blood glucose in T2DM treatment with complication of PVD would require higher cost than in T2DM treatment with complication of kidney from both perspectives. MDPI 2021-02-16 /pmc/articles/PMC7920312/ /pubmed/33669379 http://dx.doi.org/10.3390/healthcare9020211 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Priyadi, Akhmad Permana, Hikmat Muhtadi, Ahmad Sumiwi, Sri A. Sinuraya, Rano K. Suwantika, Auliya A. Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia |
title | Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia |
title_full | Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia |
title_fullStr | Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia |
title_full_unstemmed | Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia |
title_short | Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia |
title_sort | cost-effectiveness analysis of type 2 diabetes mellitus (t2dm) treatment in patients with complications of kidney and peripheral vascular diseases in indonesia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920312/ https://www.ncbi.nlm.nih.gov/pubmed/33669379 http://dx.doi.org/10.3390/healthcare9020211 |
work_keys_str_mv | AT priyadiakhmad costeffectivenessanalysisoftype2diabetesmellitust2dmtreatmentinpatientswithcomplicationsofkidneyandperipheralvasculardiseasesinindonesia AT permanahikmat costeffectivenessanalysisoftype2diabetesmellitust2dmtreatmentinpatientswithcomplicationsofkidneyandperipheralvasculardiseasesinindonesia AT muhtadiahmad costeffectivenessanalysisoftype2diabetesmellitust2dmtreatmentinpatientswithcomplicationsofkidneyandperipheralvasculardiseasesinindonesia AT sumiwisria costeffectivenessanalysisoftype2diabetesmellitust2dmtreatmentinpatientswithcomplicationsofkidneyandperipheralvasculardiseasesinindonesia AT sinurayaranok costeffectivenessanalysisoftype2diabetesmellitust2dmtreatmentinpatientswithcomplicationsofkidneyandperipheralvasculardiseasesinindonesia AT suwantikaauliyaa costeffectivenessanalysisoftype2diabetesmellitust2dmtreatmentinpatientswithcomplicationsofkidneyandperipheralvasculardiseasesinindonesia |